Floatz logo

Trifluridine

Metastatic Gastroesophageal Adenocarcinoma

UNICANCERSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

40 Active assets in the Metastatic Gastroesophageal Adenocarcinoma cohort.

Asset / SponsorPhaseRating
Eloxatin
Memorial Sloan Kettering Cancer Center
Phase 3BB
Pembrolizumab
Diwakar Davar
Phase 3BB
Nivolumab
Memorial Sloan Kettering Cancer Center
Phase 2BB
TRASTUZUMAB
UNICANCER
Phase 3BB
Capecitabine
Shanghai Zhongshan Hospital
Phase 3B

View all 50 →

Same molecule, other indications

Trifluridine is also rated in:

colorectal cancerDormant
BB
Indicative ·
67 / 100
View asset →
rectal cancerDormant
BB
Indicative ·
67 / 100
View asset →
colorectal adenocarcinomaDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →